RARECast
A podcast by RARECast - Giovedì
548 Episodio
-
Crowdsourcing Therapeutic Approaches for an Ultra-Rare Disease
Pubblicato: 05/02/2020 -
Delivering Oligonucleotide Therapies to Any Cell Type
Pubblicato: 29/01/2020 -
Protalix Looks Beyond Biobetters
Pubblicato: 22/01/2020 -
Driving N-of-1 Therapies for Ultra-Rare Disease Patients
Pubblicato: 15/01/2020 -
Cutting the Time and Cost of Drug Discovery with MicroOrgans
Pubblicato: 08/01/2020 -
Acquisition Combines Two Pipelines for Rare Skin Diseases
Pubblicato: 02/01/2020 -
Programming Cells to Produce Neuroprotective Factors to Treat ALS
Pubblicato: 26/12/2019 -
Origin's Rapid Path to Seek Approval for Treatment of Ultra-Rare Metabolic Condition
Pubblicato: 18/12/2019 -
Developing a Common Language for Rare Diseases
Pubblicato: 11/12/2019 -
Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence
Pubblicato: 04/12/2019 -
How a Brother's Love Is Forging a Path for Customized Therapies for Rare Disease Patients
Pubblicato: 27/11/2019 -
Addressing the Barriers to Accessing Experimental Therapies
Pubblicato: 20/11/2019 -
A Journey to Advocacy
Pubblicato: 13/11/2019 -
Turning Chronic Illness into a Fashion Statement
Pubblicato: 06/11/2019 -
Connecting Young Adults with Rare and Chronic Conditions
Pubblicato: 30/10/2019 -
Helping Caregivers Care for Themselves
Pubblicato: 23/10/2019 -
A Festival of Moving Pictures
Pubblicato: 16/10/2019 -
Deep Genomics Boasts an AI First in Drug Discovery
Pubblicato: 09/10/2019 -
How to Live with a Disability with Your Mojo Intact
Pubblicato: 03/10/2019 -
Why a Big Pharma Exec Embraced Rare Neurological Diseases
Pubblicato: 25/09/2019
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.